Previous Page  3 / 23 Next Page
Information
Show Menu
Previous Page 3 / 23 Next Page
Page Background

Page 34

A n n u a l S u mm i t o n

Hepatology and Pancreatic

Diseases

November 12-13 , 2018

Par i s , France

Journal of Clinical Gastroenterology and Hepatology

ISSN: 2575-7733

Hepatology and Pancreatic Diseases 2018

Introduction:

Bilirubin, a final product of heme catabolism in the intravascular compartment, belongs to the most efficient

endogenous antioxidants. Its systemic concentrations are considered to protect from diseases mediated by increased oxidative

stress, including cardiovascular, inflammatory of cancer diseases. Thus, the aim of our study was to assess the relationship

between serum bilirubin concentrations and overall, cardiovascular and cancer mortality.

Methods:

The study was performed on a Polish arm of the HAPIEE study (n=7688 in total, a subsample of 1870 subjects with

biochemical parameters), in which the associations between the serum bilirubin concentrations and bilirubin UDP-glucuronosyl

transferase (UGT1A1) promoter gene variations with overall, cardiovascular and cancer mortality were analyzed.

Results:

Strong negative correlation between serum bilirubin levels and cancer mortality (p<0.001) was detected; this association

was expressed more in men. Subjects in the lowest bilirubin quartile (again in particular men), had, as compared to other quartiles,

significantly higher both overall and cancer mortality (p<0.001 for both comparisons). Negative relationship of bilirubin to

cardiovascular mortality was surprisingly much less expressed. Similarly, negative relationship to overall and non-cardiovascular

mortality was observed in men (but not women) with Gilbert syndrome phenotype (benign hyperbilirubinemia) (p<0.01). On the

other hand, these associations were not observed with

UGT1A1

promoter gene variations, most likely due to limited penetrance

of this gene mutation.

Conclusion:

Serum bilirubin concentrations are a significant negative predictor of total mortality; this association is mostly driven

by the effect on a cancer, and much less on cardiovascular mortality. These relationships are primarily pronounced in male

population, most likely due to physiologically higher systemic bilirubin.

UGT1A1

promoter gene variations do not seem to have

any major role on predicting mortality

vitek@cesnet.cz

Serum bilirubin is an important predictor of

cancer mortality: results from the Polish arm of

the HAPIEE study

Vitek L

1

, Hubacek JA

2

, Pajak A

3

, Eremiasova L

1

, Danzig V

1

,

Stefler D

4

, Bobak M

4

1

Charles University, Czech Republic

2

Institute for Clinical and Experimental Medicine, Czech Republic

3

Jagiellonian University, Poland

4

University College of London, UK

J Clin Gastroenterol Hepatol 2018, Volume:2

DOI: 10.21767/2575-7733-C3-009